Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 338

1.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T; CHARTER Study Group.

Mol Neurobiol. 2018 Sep 12. doi: 10.1007/s12035-018-1329-9. [Epub ahead of print]

PMID:
30209774
2.

Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.

Kallianpur AR, Gerschenson M, Hulgan T, Kaur H, Clifford DB, Haas DW, Murdock DG, McArthur JC, Samuels DC, Simpson DM.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):942-949. doi: 10.1089/AID.2018.0025. Epub 2018 Aug 22.

PMID:
29968489
3.

Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse.

Nedelcovych MT, Gadiano AJ, Wu Y, Manning AA, Thomas AG, Khuder SS, Yoo SW, Xu J, McArthur JC, Haughey NJ, Volsky DJ, Rais R, Slusher BS.

ACS Chem Neurosci. 2018 Apr 18;9(4):809-816. doi: 10.1021/acschemneuro.7b00434. Epub 2018 Jan 4.

4.

Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.

Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte T, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, Tharakan R, McArthur JC, Fox H, Haughey NJ.

AIDS. 2017 Jun 19;31(10):1365-1378. doi: 10.1097/QAD.0000000000001503.

5.

The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, Borsook D, Edwards RR, Harris RE, Wager TD, Arendt-Nielsen L, Burke LB, Carr DB, Chappell A, Farrar JT, Freeman R, Gilron I, Goli V, Haeussler J, Jensen T, Katz NP, Kent J, Kopecky EA, Lee DA, Maixner W, Markman JD, McArthur JC, McDermott MP, Parvathenani L, Raja SN, Rappaport BA, Rice ASC, Rowbotham MC, Tobias JK, Wasan AD, Witter J.

J Pain. 2017 Jul;18(7):757-777. doi: 10.1016/j.jpain.2017.02.429. Epub 2017 Feb 27. Review.

6.

PML in natalizumab-treated multiple sclerosis: Modeling errors and risk miscalculations.

Mowry EM, McArthur JC.

Neurology. 2017 Mar 21;88(12):1110-1111. doi: 10.1212/WNL.0000000000003749. Epub 2017 Feb 22. No abstract available.

PMID:
28228562
7.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

Anderson AM, Muñoz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Franklin DR, Heaton RK, Grant I, Letendre SL; CHARTER Group.

J Infect Dis. 2017 Jan 1;215(1):105-113. doi: 10.1093/infdis/jiw505. Epub 2016 Oct 26.

8.

Pearls and Pitfalls, Part 2.

McArthur JC, Schiess N.

Semin Neurol. 2016 Oct;36(5):407-408. Epub 2016 Sep 23. No abstract available.

PMID:
27704494
9.

Pearls and Pitfalls, Part 1.

McArthur JC, Schiess N.

Semin Neurol. 2016 Aug;36(4):315-6. doi: 10.1055/s-0036-1586259. Epub 2016 Sep 19. No abstract available.

PMID:
27643897
10.

Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy.

Gewandter JS, Burke L, Cavaletti G, Dworkin RH, Gibbons C, Gover TD, Herrmann DN, Mcarthur JC, McDermott MP, Rappaport BA, Reeve BB, Russell JW, Smith AG, Smith SM, Turk DC, Vinik AI, Freeman R.

Muscle Nerve. 2017 Mar;55(3):366-372. doi: 10.1002/mus.25264. Epub 2016 Dec 23. Review.

11.

HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment.

Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC.

Nat Rev Neurol. 2016 May;12(5):309. doi: 10.1038/nrneurol.2016.53. Epub 2016 Apr 15. No abstract available.

12.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.

Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Oct;22(5):607-614. Epub 2016 Mar 28.

13.

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC.

Nat Rev Neurol. 2016 Apr;12(4):234-48. doi: 10.1038/nrneurol.2016.27. Epub 2016 Mar 11. Review. Erratum in: Nat Rev Neurol. 2016 May;12(5):309.

14.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.

Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, Mcarthur JC; CHARTER Group.

J Neurovirol. 2016 Aug;22(4):479-87. doi: 10.1007/s13365-015-0416-1. Epub 2016 Jan 4.

15.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I; CHARTER Study Group.

J Infect Dis. 2016 Apr 1;213(7):1065-73. doi: 10.1093/infdis/jiv754. Epub 2015 Dec 21.

16.

In memoriam: Richard T. Johnson, 1931-2015.

McArthur JC, Nath A.

Ann Neurol. 2016 Jan;79(1):9-10. doi: 10.1002/ana.24576. No abstract available.

PMID:
26660084
17.

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.

Ma Q, Vaida F, Wong J, Sanders CA, Kao YT, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, Morgello S, Simpson DM, Heaton RK, Grant I, Letendre SL; CHARTER Group.

J Neurovirol. 2016 Apr;22(2):170-8. doi: 10.1007/s13365-015-0382-7. Epub 2015 Sep 25.

18.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre SL, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Kallianpur AR; CHARTER Group.

Clin Infect Dis. 2015 Nov 1;61(9):1476-84. doi: 10.1093/cid/civ527. Epub 2015 Jun 30.

19.

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.

Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Letendre SL; CHARTER Group.

J Neurovirol. 2015 Oct;21(5):559-67. doi: 10.1007/s13365-015-0359-6. Epub 2015 Jun 12.

20.

Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.

Figuera-Losada M, Stathis M, Dorskind JM, Thomas AG, Bandaru VV, Yoo SW, Westwood NJ, Rogers GW, McArthur JC, Haughey NJ, Slusher BS, Rojas C.

PLoS One. 2015 May 26;10(5):e0124481. doi: 10.1371/journal.pone.0124481. eCollection 2015.

21.

Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.

Shikuma CM, Bennett K, Ananworanich J, Gerschenson M, Teeratakulpisarn N, Jadwattanakul T, DeGruttola V, McArthur JC, Ebenezer G, Chomchey N, Praihirunkit P, Hongchookiat P, Mathajittiphun P, Nakamoto B, Hauer P, Phanuphak P, Phanuphak N; SEARCH 003 protocol team.

J Neurovirol. 2015 Oct;21(5):525-34. doi: 10.1007/s13365-015-0352-0. Epub 2015 May 22.

22.

Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients.

Dickens AM, Anthony DC, Deutsch R, Mielke MM, Claridge TD, Grant I, Franklin D, Rosario D, Marcotte T, Letendre S, McArthur JC, Haughey NJ.

AIDS. 2015 Mar 13;29(5):559-69. doi: 10.1097/QAD.0000000000000580.

23.

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.

Clifford DB, Vaida F, Kao YT, Franklin DR, Letendre SL, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Grant I, Heaton RK; CHARTER Group.

Neurology. 2015 Jan 20;84(3):241-50. doi: 10.1212/WNL.0000000000001156. Epub 2014 Dec 10.

24.

CNS infections in 2014: Guns, germs, and will.

Thakur KT, McArthur JC, Venkatesan A.

Lancet Neurol. 2015 Jan;14(1):20-2. doi: 10.1016/S1474-4422(14)70293-5. No abstract available.

25.

Neuroinflammation and virus replication in the spinal cord of simian immunodeficiency virus-infected macaques.

Mangus LM, Dorsey JL, Laast VA, Hauer P, Queen SE, Adams RJ, McArthur JC, Mankowski JL.

J Neuropathol Exp Neurol. 2015 Jan;74(1):38-47. doi: 10.1097/NEN.0000000000000148.

26.

Controversies in HIV-associated neurocognitive disorders.

Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T.

Lancet Neurol. 2014 Nov;13(11):1139-1151. doi: 10.1016/S1474-4422(14)70137-1. Review.

27.

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.

Archibald SL, McCutchan JA, Sanders C, Wolfson T, Jernigan TL, Ellis RJ, Ances BM, Collier AC, McArthur JC, Morgello S, Simpson DM, Marra C, Gelman BB, Clifford DB, Grant I, Fennema-Notestine C; CHARTER Group.

J Neurovirol. 2014 Dec;20(6):603-11. doi: 10.1007/s13365-014-0284-0. Epub 2014 Sep 17.

28.

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, McArthur JC, Clifford DB, Collier AC, Gelman BB, McCutchan JA, Franklin D, Samuels DC, Rosario D, Holzinger E, Murdock DG, Letendre S, Grant I; CHARTER Study Group.

PLoS One. 2014 Aug 21;9(8):e103123. doi: 10.1371/journal.pone.0103123. eCollection 2014.

29.

Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry.

Bora A, Ubaida Mohien C, Chaerkady R, Chang L, Moxley R 4th, Sacktor N, Haughey N, McArthur JC, Cotter R, Nath A, Graham DR.

J Neurovirol. 2014 Oct;20(5):457-65. doi: 10.1007/s13365-014-0263-5. Epub 2014 Jul 24.

30.

The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.

Hammond ER, Crum RM, Treisman GJ, Mehta SH, Marra CM, Clifford DB, Morgello S, Simpson DM, Gelman BB, Ellis RJ, Grant I, Letendre SL, McArthur JC; CHARTER Group.

Am J Epidemiol. 2014 Aug 1;180(3):297-307. doi: 10.1093/aje/kwu098. Epub 2014 Jun 24.

31.

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

Grant I, Franklin DR Jr, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK; CHARTER Group.

Neurology. 2014 Jun 10;82(23):2055-62. doi: 10.1212/WNL.0000000000000492. Epub 2014 May 9.

32.

Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy.

Hulgan T, Levinson RT, Gerschenson M, Phanuphak N, Ananworanich J, Teeratakulpisarm N, Jadwattanakul T, LiButti DE, Fink H, McArthur JC, Ebenezer GJ, Hauer P, Murdock D, Shikuma CM, Samuels DC; SEARCH 003 Study Team.

AIDS. 2014 Jul 17;28(11):1625-33. doi: 10.1097/QAD.0000000000000297.

33.

Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort.

Biswas B, Spitznagel E, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB; the CHARTER Group.

J HIV AIDS Soc Serv. 2014 Jan 1;13(1):8-25.

34.

The armadillo as a model for peripheral neuropathy in leprosy.

Truman RW, Ebenezer GJ, Pena MT, Sharma R, Balamayooran G, Gillingwater TH, Scollard DM, McArthur JC, Rambukkana A.

ILAR J. 2014;54(3):304-14. doi: 10.1093/ilar/ilt050. Review.

35.

Reply: To PMID 23722610.

Gamaldo CE, Gamaldo A, McArthur JC, Smith MT.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):e124-5. doi: 10.1097/QAI.0000000000000042. No abstract available.

36.

A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder.

Rosenthal LS, Skolasky RL, Moxley RT 4th, Roosa HV, Selnes OA, Eschman A, McArthur JC, Sacktor N.

J Neurovirol. 2013 Oct;19(5):432-41. doi: 10.1007/s13365-013-0195-5. Epub 2013 Oct 1.

37.

Older individuals with HIV infection have greater memory deficits than younger individuals.

Tan IL, Smith BR, Hammond E, Vornbrock-Roosa H, Creighton J, Selnes O, McArthur JC, Sacktor N.

J Neurovirol. 2013 Dec;19(6):531-6.

38.

A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects.

Bandaru VV, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ.

Neurology. 2013 Oct 22;81(17):1492-9. doi: 10.1212/WNL.0b013e3182a9565e. Epub 2013 Sep 11.

39.

Predictors of outcome in acute encephalitis.

Thakur KT, Motta M, Asemota AO, Kirsch HL, Benavides DR, Schneider EB, McArthur JC, Geocadin RG, Venkatesan A.

Neurology. 2013 Aug 27;81(9):793-800. doi: 10.1212/WNL.0b013e3182a2cc6d. Epub 2013 Jul 26.

40.

Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre SL, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau DJ, Wolfson T, Heaton RK, Gamst AC, Franklin DR Jr, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I; CHARTER Group.

J Neurovirol. 2013 Aug;19(4):393-401. doi: 10.1007/s13365-013-0185-7. Epub 2013 Jul 10.

41.

Brainstem encephalitis: etiologies, treatment, and predictors of outcome.

Tan IL, Mowry EM, Steele SU, Pardo CA, McArthur JC, Nath A, Venkatesan A.

J Neurol. 2013 Sep;260(9):2312-9. doi: 10.1007/s00415-013-6986-z. Epub 2013 Jun 9.

42.

Evaluating sleep and cognition in HIV.

Gamaldo CE, Gamaldo A, Creighton J, Salas RE, Selnes OA, David PM, Mbeo G, Parker BS, Brown A, McArthur JC, Smith MT.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):609-16. doi: 10.1097/QAI.0b013e31829d63ab.

43.

Ethnic differences in epidermal nerve fiber density.

Shikuma CM, McArthur JC, Ebenezer GJ, Ananworanich J, Teeratakulpisarn N, Jadwattanakul T, Valcour VG, Bennett K, Phanuphak N; SEARCH 014 Protocol Team.

Muscle Nerve. 2013 Sep;48(3):462-4. doi: 10.1002/mus.23834. Epub 2013 Jul 27. No abstract available.

44.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.

Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2013 Apr;19(2):150-6. doi: 10.1007/s13365-013-0152-3. Epub 2013 Feb 14.

45.

Clinical reasoning: Multiple cranial neuropathies in a young man.

Probasco JC, Munchel AT, McArthur JC, Blakeley JO.

Neurology. 2013 Feb 5;80(6):e60-6. doi: 10.1212/WNL.0b013e3182815441. No abstract available.

46.

Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders.

Bachani M, Sacktor N, McArthur JC, Nath A, Rumbaugh J.

J Neurovirol. 2013 Feb;19(1):82-8. doi: 10.1007/s13365-012-0144-8. Epub 2013 Jan 18.

47.

Sleep, function and HIV: a multi-method assessment.

Gamaldo CE, Spira AP, Hock RS, Salas RE, McArthur JC, David PM, Mbeo G, Smith MT.

AIDS Behav. 2013 Oct;17(8):2808-15. doi: 10.1007/s10461-012-0401-0.

48.

Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration.

Avery LB, Sacktor N, McArthur JC, Hendrix CW.

Antimicrob Agents Chemother. 2013 Mar;57(3):1409-14. doi: 10.1128/AAC.02329-12. Epub 2013 Jan 7. Erratum in: Antimicrob Agents Chemother. 2013 Aug;57(8):4095.

49.

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.

Andrade AS, Deutsch R, A Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur JC, Marra C, Grant I, Collier AC.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):282-92. doi: 10.1097/QAI.0b013e31827ed678.

50.

Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised.

Tan IL, McArthur JC, Venkatesan A, Nath A.

Neurology. 2012 Nov 20;79(21):2125-32. doi: 10.1212/WNL.0b013e3182752ceb. Epub 2012 Nov 7.

Supplemental Content

Loading ...
Support Center